期刊簡介 | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | JOURNAL OF SURGICAL ONCOLOGY LetPub Score 6.7
50 ratings
Rate
Reputation 7.5 Influence 5.3 Speed 9.6 | ||||||||||||||||||||
期刊簡稱 | J SURG ONCOL | ||||||||||||||||||||
ISSN | 0022-4790 | ||||||||||||||||||||
E-ISSN | 1096-9098 | ||||||||||||||||||||
h-index | 101 | ||||||||||||||||||||
CiteScore |
| ||||||||||||||||||||
自引率 (2023-2024) | 5.00%自引率趨勢 | ||||||||||||||||||||
掲載範囲 |
| ||||||||||||||||||||
官方網站 | http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1096-9098 | ||||||||||||||||||||
在線稿件提交 | http://mc.manuscriptcentral.com/jso | ||||||||||||||||||||
開放訪問 | No | ||||||||||||||||||||
出版商 | Wiley-Liss Inc. | ||||||||||||||||||||
主題領域 | 医学 | ||||||||||||||||||||
出版國/地區 | UNITED STATES | ||||||||||||||||||||
發行頻率 | 月2回刊行 | ||||||||||||||||||||
創刊年 | 0 | ||||||||||||||||||||
每年文章數 | 313每年文章數趨勢 | ||||||||||||||||||||
黃金OA百分比 | 13.31% | ||||||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q2
| ||||||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Science Citation Index Expanded | ||||||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0022-4790%5BISSN%5D | ||||||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: Average 2 Month(s) | ||||||||||||||||||||
競爭力 * | 來自作者的數據: About 50% | ||||||||||||||||||||
參考鏈接 |
| ||||||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 2 3 4 5 下一頁 末頁 (頁 | |
[JOURNAL OF SURGICAL ONCOLOGY] 的評論 | 撰寫評論 |
作者: yh417 領域: 医学 審稿時間: 4.0 month(s) 結果: 修改後接受 撰寫評論 |
2024-05-13 10:14:54 評論於 A liver cancer meta, submitted on January 20th, had no updates for over a month. An email was sent to urge the process at the end of February, and it was then put under review. On March 8th, a major revision was requested with a three-month deadline, and a response was given within two weeks. Minor revisions were made on April 7th. The submission website was changed to Wiley halfway through the process, and the article was resubmitted on April 20th. Finally, it was accepted on May 11th(0) 讚! | yh417 |
作者: 是你的笑丝呀 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-03-16 20:34:47 評論於 How did he figure out the citation errors in the reference list?(0) 讚! | 是你的笑丝呀 |
作者: 格洛丽亚瑞林 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-01-10 09:29:39 評論於 Review Speed: 1.0 | Acceptance Rate: 25.0 Emphasis on research direction: Liver cancer Experience sharing: Submitted on 2023.1.6, rejected on 1.9, the review was fast enough, but no reason given(0) 讚! | 格洛丽亚瑞林 |
作者: 博泽少爷 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-12-29 12:38:51 評論於 Main research focus: Tumors; Cancer; Prognosis Experience sharing: Submitted on 11.30, under review. Received comments from one associate editor and one reviewer on 12.29, with a 3-month revision period. Completed revisions and now waiting for the final decision. Overall, the process has been very fast(0) 讚! | 博泽少爷 |
作者: 北风梓璐 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-10-30 13:25:04 評論於 Is there an option in this magazine where we don't have to pay for the editorial fee?(0) 讚! | 北风梓璐 |
作者: Abner Maria 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-10-30 09:39:38 評論於 Review speed: 1.0 | Submission acceptance rate: 50.0 Research focus: Cancer; Clinical Experience: #Clinical Retrospective Analysis# [HU] Sharing submission experience is like giving roses ? 10-1 submitted 10-1 under review 10-27 awaiting EIC Decision 10-29 Reject Rejection letter details: Your manuscript entitled, "..........," (JSO-2022-....) was reviewed by the Editorial Committee of Journal of Surgical Oncology. After careful consideration, the manuscript was not recommended for publication in the Journal. This decision reflects the priority that the manuscript was assigned in relation to competing submissions. Summary: The review process is fast, focusing on large sample clinical studies, with retrospective analysis of cases fewer than 100 generally not accepted(0) 讚! | Abner Maria |
作者: guanhong123 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-10-28 23:46:46 評論於 May I ask if your article is of the research type or review type? I heard that meta takes a bit longer, is that true? I submitted a meta article and it is still under review.(0) 讚! | guanhong123 |
作者: guanhong123 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-10-28 23:43:49 評論於 Did the paper get rejected after being revised?(0) 讚! | guanhong123 |
作者: 太虚安澜 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-10-28 16:41:12 評論於 As soon as I submitted it, it is under review. May I ask how long it takes to receive the review comments?(0) 讚! | 太虚安澜 |
作者: Miranda 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-08-18 09:39:11 評論於 Instant rejection, rejected to the point of doubting life(0) 讚! | Miranda |
作者: Miranda 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-08-17 23:36:14 評論於 Hey guys, how long until the situation changes?(0) 讚! | Miranda |
作者: Miranda 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-08-16 10:26:44 評論於 Emphasis on research direction: Hepatocellular carcinoma radiotherapy; prognosis; clinical experience sharing: Does anyone have any big names to share submissions to this journal?(0) 讚! | Miranda |
作者: 一只幻南呀 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-06-01 20:52:56 評論於 It seems that this magazine is just like this(0) 讚! | 一只幻南呀 |
作者: 金顶代丹 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-05-30 13:48:22 評論於 Is anyone else having trouble uploading pictures? How do I go about fixing this craziness?(0) 讚! | 金顶代丹 |
作者: Catcher 領域: 医学 審稿時間: 9.0 month(s) 結果: 直接被接受 撰寫評論 |
2022-05-01 10:15:34 評論於 The submission period mentioned above is incorrect. Professors, please disregard that. The review process is fast, so you can give it a try!(0) 讚! | Catcher |
作者: Catcher 領域: 医学 審稿時間: 9.0 month(s) 結果: 直接被接受 撰寫評論 |
2022-05-01 10:13:40 評論於 3.30 submitted, accepted in the early morning of 5.1, submitted for a month, no revisions required, accepted directly, very fast process, thumbs up (previously had to revise twice for another lower-ranked journal, reviewers were all satisfied, but the editor rejected it, took six months, felt disgusted).(3) 讚! | Catcher |
作者: 冰心凝蝶 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-03-29 20:07:52 評論於 Hello, I have been waiting for a week after submitting my manuscript. It has been "Under Review" all this time. How do I know if it has been sent for external review?(0) 讚! | 冰心凝蝶 |
作者: 冰心凝蝶 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-03-29 19:21:35 評論於 How do I know if it has been sent for external review? I have been under review for a week since submitting my contribution(0) 讚! | 冰心凝蝶 |
作者: 冰心凝蝶 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-03-29 16:24:08 評論於 Hello, it has been 1 week since I submitted my manuscript, and it is still Under Review. Is the journal considering sending it out for external review?(0) 讚! | 冰心凝蝶 |
作者: 冰心凝蝶 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-03-29 08:40:10 評論於 Hello, how do you see if it has been sent for external review? It is still Under Review from the beginning(0) 讚! | 冰心凝蝶 |
作者: Perry Adam 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-03-28 15:14:05 評論於 Within a month, three months were given to modify, and then rejected(0) 讚! | Perry Adam |
作者: Perry Adam 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-03-28 08:12:46 評論於 Within one month(0) 讚! | Perry Adam |
作者: 极乐景逸 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-02-09 20:10:53 評論於 Does this magazine accept articles related to genetics?(0) 讚! | 极乐景逸 |
作者: Martina Jeremy 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-23 23:35:31 評論於 Submission hit rate: 25.0 Research orientation: Tumor Experience sharing: The submission was rejected after 1 day, with a claim of a 15% acceptance rate(0) 讚! | Martina Jeremy |
作者: Norma Jane 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-02 12:06:56 評論於 Rejected the next day(0) 讚! | Norma Jane |
首頁 上一頁 1 2 3 4 5 下一頁 末頁 (頁 |
Contact us